Despite a generally sluggish freight environment in 2025, the health care logistics segment stood out as a strong performer and a key area of growth as major carriers and logistics firms intensified focus on high‑margin, resilient supply chains.
Industry heavyweights including UPS, DHL and GXO led acquisition and expansion activity in the sector throughout the year, reflecting confidence in health care supply chain demand that has remained robust even as other freight volumes softened. Among the landmark transactions was UPS’ $1.6 billion purchase of Andlauer Healthcare Group, a cold‑chain specialist, intended to speed transit, enhance visibility and expand global coverage for pharmaceutical and medical device logistics.
DHL Group also made multiple strategic moves to deepen its health care logistics capabilities, acquiring specialist providers in clinical trials, biopharma and final‑mile delivery operations — moves designed to support expanded service offerings from temperature‑controlled transport to specialized health system networks.
GXO Logistics secured major contracts such as its multibillion‑dollar NHS Supply Chain deal in England and Wales, positioning the company as a logistics partner for large‑scale health care distribution and further aligning with demand trends in life sciences logistics.
FedEx has similarly signalled strong engagement with the segment, targeting significant health care revenue growth as part of its broader business strategy, with expectations to generate billions in health care‑related revenue by the end of fiscal 2025.
The sustained interest from top global logistics players underscores the sector’s resilience and long‑term growth prospects — driven by demographic shifts, increasing medical complexity and the rising importance of reliable, time‑critical shipments such as pharmaceuticals, clinical materials and specialty medical goods.
#BreakingNews #SupplyChainNews #HealthcareLogistics #LogisticsGrowth #ColdChain
